Presentation characteristics, risk profiles and long-term outcomes in a public health system, minority patient population with diffuse large B-cell lymphoma

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 8590-8590
Author(s):  
S. Sreenivasappa ◽  
S. Nathan ◽  
L. Fochesatto ◽  
T. Braik ◽  
N. Ignatius ◽  
...  
Keyword(s):  
Public Health ◽  
B Cell ◽  
Public Health System ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Minority Patient ◽  
Long Term Outcomes ◽  
Large B Cell Lymphoma ◽  
Large B Cell

scholarly journals T cell/histiocyte‐rich large B cell lymphoma: incidence, demographic disparities, and long‐term outcomes

2018 ◽  
Vol 185 (1) ◽  
pp. 140-142 ◽  
Author(s):  
Anuhya Kommalapati ◽  
Sri Harsha Tella ◽  
Ronald S. Go ◽  
Grzegorz S. Nowakowski ◽  
Gaurav Goyal
Keyword(s):  
T Cell ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Long Term Outcomes ◽  
Large B Cell Lymphoma ◽  
Large B Cell

ABCL-170: Long-Term Outcomes from the Phase II L-MIND Study of Tafasitamab (MOR208) Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

2020 ◽  
Vol 20 ◽  
pp. S267-S268
Author(s):  
Gilles Salles ◽  
Johannes Duell ◽  
Eva González-Barca ◽  
Wojciech Jurczak ◽  
Anna Marina Liberati ◽  
...  
Keyword(s):  
B Cell ◽  
Phase Ii ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Long Term Outcomes ◽  
Large B Cell Lymphoma ◽  
Large B Cell

scholarly journals Long-Term Survival and Gradual Recovery of B Cells in Patients (Pts) with Refractory Large B Cell Lymphoma (LBCL) Treated with Axicabtagene Ciloleucel (Axi-Cel)

2021 ◽  
Vol 27 (3) ◽  
pp. S404-S405
Author(s):  
Caron A. Jacobson ◽  
Frederick L. Locke ◽  
Armin Ghobadi ◽  
David B. Miklos ◽  
Lazaros J. Lekakis ◽  
...  
Keyword(s):  
B Cells ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Term Survival ◽  
Long Term Survival ◽  
Large B Cell Lymphoma ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document